Nomir Medical To Present Positive Onychomycosis Data For Its Noveon(R) Dual Wavelength Device
Nomir Medical Technologies, a leader in the development of optical energy technologies for anti-infective medical applications, announced that the Company will present an abstract detailing positive in vitro and in vivo human data from its study of onychomycosis (toe nail fungus) using Noveon®, a novel dual wavelength optical energy device.
Mail this post 
Health is the Most Precious Asset to us! Just willing to share with you what I have learned from Nutriotional Immunology.
